David Lee Lampi Hermanson

Title: David Lee Lampi Hermanson: Innovator in Chimeric Antigen Receptors

Introduction

David Lee Lampi Hermanson is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors. With a total of 2 patents, his work is paving the way for advancements in cancer treatment and immunotherapy.

Latest Patents

Hermanson's latest patents focus on chimeric antigen receptors for expression in Natural Killer (NK) cells. These patents describe pharmaceutical compositions that include NK cells and/or induced pluripotent stem cells (iPSCs) modified to express a chimeric antigen receptor. The chimeric antigen receptor generally consists of an ectodomain that includes an antigen recognition region, a transmembrane domain linked to the ectodomain, and an endodomain linked to the transmembrane domain. The endodomain can include a signaling peptide that activates an NK cell, enhancing the immune response against cancer cells.

Career Highlights

David Lee Lampi Hermanson is affiliated with the University of Minnesota, where he continues to innovate and contribute to research in the field of immunotherapy. His work is instrumental in developing new therapeutic strategies that leverage the body's immune system to fight cancer.

Collaborations

Some of Hermanson's notable coworkers include Dan Samuel Kaufman and Branden Moriarity. Their collaborative efforts are focused on advancing the understanding and application of chimeric antigen receptors in clinical settings.

Conclusion

David Lee Lampi Hermanson is a prominent figure in the field of biotechnology, with a focus on chimeric antigen receptors that hold promise for future cancer therapies. His innovative work continues to inspire advancements in immunotherapy and the treatment of various diseases.